EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Being attack-free is associated with improved quality of life for patients with hereditary angioedema treated with garadacimab: Post hoc analysis from the pivotal Phase 3 (VANGUARD) study

Monday 03 Jun, 13:06 PM - 13:13 PM Valencia, Spain